greatli
augment
transaminas
plasmat
level
neutral
affect
liber
slightli
augment
plasmat
uric
acid
concentr
howev
mice
treat
mab
fail
produc
autoab
fah
result
suggest
reciproc
regul
cell
act
differ
effect
addit
propos
involv
alarmin
adjuv
effect
lead
autoab
express
interleukin
famili
cytokin
among
consid
one
major
proinflammatori
cytokin
central
innat
adapt
immun
respons
particularli
level
correl
varieti
hepat
disord
wherea
anoth
famili
member
current
defin
role
hepat
ill
interest
signal
heterodimer
receptor
consist
subunit
express
ubiquit
includ
express
resid
liver
cell
play
import
role
host
immun
extracellular
pathogen
chronic
inflammatori
condit
rheumatoid
arthriti
psoriasi
multipl
sclerosi
addit
suggest
import
factor
pathogenesi
primari
biliari
cirrhosi
autoimmun
hepat
hepat
b
data
studi
indic
plasma
level
also
elev
patient
alcohol
hepat
cirrhosi
mous
hepat
virus
mhv
belong
coronaviru
group
induc
acut
subclin
hepat
neurolog
respiratori
orand
enter
diseas
mice
accord
serotyp
highli
hepatotrop
mous
hepat
viru
type
known
virul
mhv
strain
caus
fulmin
hepat
death
suscept
mice
within
day
postinfect
neurolog
diseas
follow
nonleth
hepat
semisuscept
mice
weakli
hepatotrop
caus
mortal
moder
hepat
without
neurolog
diseas
mice
inocul
intraperiton
brain
invas
diseas
serotyp
howev
enabl
follow
intranas
infect
liver
dysfunct
mice
result
sever
foci
extens
necrosi
contrast
observ
liver
mice
infect
serotyp
mhv
serotyp
use
molecul
viral
receptor
infect
host
cell
interact
viral
surfac
protein
previous
demonstr
differenti
level
viral
replic
hepat
induc
mhv
serotyp
larg
relat
viral
protein
suggest
interact
protein
molecul
may
reflect
virul
liver
report
presenc
autoantibodi
autoab
liver
kidney
fumarylacetoacet
hydrolas
fah
sera
variou
mous
strain
infect
shown
express
antifah
autoab
close
associ
releas
danger
signal
uric
acid
highmobl
group
box
protein
establish
new
experiment
model
autoimmun
hepat
aih
treat
balbc
mice
carbon
tetrachlorid
infect
use
mice
strain
suscept
balbc
spontan
develop
sever
sign
aih
infect
hypergammaglobulinemia
autoab
liver
antigen
ag
elev
transaminas
interestingli
liver
infiltr
zhao
et
al
found
plasma
concentr
elev
patient
aih
compar
control
patient
liver
diseas
thu
studi
whether
implic
model
aih
explor
effect
neutral
monoclon
antibodi
mab
cytokin
variou
biolog
paramet
affect
viru
neutral
mab
result
decreas
level
mous
transaminas
antifah
autoab
induc
viru
increas
ig
serum
concentr
secret
surviv
infect
anim
well
liver
patholog
affect
mab
furthermor
result
mous
treatment
mab
andor
strongli
suggest
interplay
cell
act
mice
specificpathogenfre
spf
femal
mice
univers
la
plata
argentina
use
age
week
anim
maintain
isol
standard
laboratori
chow
spf
condit
end
experi
receiv
care
complianc
intern
legal
requir
nctc
adher
cell
line
deriv
normal
mous
liver
purchas
american
type
cultur
collect
cell
grow
bottl
inocul
viru
multipl
adsorpt
period
hour
c
ml
nctc
medium
fetal
calf
serum
ad
bottl
incub
c
sever
cycl
freez
thaw
use
releas
viru
hour
inocul
harvest
viru
centrifug
g
min
remov
debri
supernat
frozen
c
storag
viru
titrat
endpoint
method
perform
inocul
serial
dilut
stock
onto
cell
monolay
plate
hour
well
viral
cytopath
effect
count
dilut
titer
express
tissu
infecti
dose
mice
infect
day
postinfect
anim
inocul
intraperiton
g
mab
mab
andor
mab
l
pb
mice
bled
day
infect
treatment
antihuman
growth
hormon
mab
use
control
ab
biotinyl
mab
gmous
inocul
day
four
balbc
mice
day
anim
bled
serum
concentr
mab
complex
measur
elisa
assay
describ
serum
concentr
measur
sandwich
elisa
maxisorb
nuncimmunopl
nunc
intern
hereford
uk
coat
overnight
mab
describ
block
bsa
l
mous
serum
ad
captur
reveal
biotinyl
mab
gml
follow
dilut
peroxidaseconjug
streptavidin
biolegend
inc
ca
usa
substrat
orthophenylenediaminedihydrochlorid
opd
sigma
chemic
co
st
loui
mo
usa
freshli
ad
h
reaction
stop
min
addit
h
absorpt
measur
elisa
reader
biotrak
ii
visibl
plate
reader
ge
healthcar
piscataway
ny
nm
standard
recombin
mous
biolegend
inc
ca
usa
measur
concentr
biotinyl
mab
complex
elisa
assay
perform
describ
use
mab
captur
ab
control
normal
mous
serum
use
instead
serum
treat
anim
micropl
nunc
maxisorb
coat
l
phosphat
buffer
salin
pb
contain
dilut
rabbit
antiserum
direct
mous
ig
plate
block
hour
c
tri
nacl
ph
tm
contain
nonfat
milk
tmsm
incub
serial
dilut
mous
serum
medium
hour
c
wash
pb
contain
ml
tween
per
liter
pbstween
plate
incub
hour
c
peroxidaselabel
goat
direct
mous
igg
santa
cruz
biotechnolog
ca
usa
dilut
tmsm
reaction
reveal
describ
paragraph
liver
noninfect
mice
remov
soak
chill
pb
ground
omni
mixer
homogen
omni
intern
inc
usa
c
volum
pb
contain
mm
phenylmethylsulfonyl
fluorid
pmsf
uml
trypsin
inhibitor
homogen
centrifug
min
g
clarifi
extract
kept
c
use
protein
concentr
determin
accord
bradford
method
determin
autoab
antifah
essenti
reactiv
autoab
antifah
determin
indic
previous
briefli
total
liver
extract
g
protein
subject
sdspage
transfer
onto
nitrocellulos
sheet
ge
healthcar
buckinghamshir
uk
strip
incub
overnight
c
mm
tri
nacl
vv
tween
ph
tbsmt
hour
room
temperatur
indic
serum
dilut
sever
wash
tb
contain
tween
bound
ab
reveal
peroxidas
label
goat
mous
igg
santa
cruz
biotechnolog
ca
usa
dilut
tbsmt
piercetm
ecl
plu
western
blot
substrat
thermo
fisher
rocheford
il
usa
mous
sera
filter
centricon
millipor
corp
usa
clear
sampl
macromolecular
complex
concentr
centricon
separ
sdspolyacrilamid
gel
westernblot
analysi
carri
describ
reveal
mab
santa
cruz
biotechnolog
ca
usa
dilut
liver
control
treat
mice
n
condit
remov
wash
pb
cut
block
fix
immers
paraformaldehyd
phosphat
buffer
ph
fixat
tissu
dehydr
grade
alcohol
embed
paraffin
fivemicromet
tissu
section
cut
dewax
hydrat
nucleistain
weigert
hematoxylin
biopur
rosario
argentina
eight
minut
collagenspecif
stain
section
immers
picrosiriu
red
solut
direct
red
sigmaaldrich
inc
illinoi
mo
usa
picric
acid
satur
solut
one
hour
stain
section
wash
glacial
acet
acid
dehydr
mount
tissu
imag
obtain
axiolab
zeiss
light
microscop
equip
cooleddigit
camera
olympu
serum
aspart
aminotransferas
ast
alanin
aminotransferas
alt
determin
use
got
ast
gpt
alt
unitest
wiener
lab
rosario
argentina
plasmat
concentr
alkalin
phosphatas
calcul
use
alp
test
wiener
lab
rosario
argentina
uric
acid
determin
enzymat
use
assay
kit
uricostat
wiener
lab
rosario
argentina
dilut
mous
sera
indic
manufactur
plasma
concentr
determin
elisa
use
mab
coat
biotinyl
mab
detect
jacqu
van
snick
ludwig
cancer
research
brussel
belgium
micropl
nunc
maxisorb
coat
l
mm
glycin
mm
nacl
ph
contain
gml
coat
mab
incub
overnight
plate
wash
block
l
pb
contain
bsa
follow
sever
wash
l
serum
dilut
bsa
ad
well
plate
incub
hour
c
wash
afterward
l
bsa
contain
detect
ab
ad
plate
incub
hour
c
wash
l
streptavidinperoxidas
biolegend
inc
ca
usa
dilut
pbst
ad
incub
min
c
sever
wash
plate
reveal
opd
describ
elisa
assay
interferon
determin
indic
mous
elisa
set
concentr
measur
describ
mous
elisa
set
test
bd
bioscienc
pharmingen
san
diego
ca
usa
statist
signific
experiment
valu
calcul
use
student
ttest
kaplanmei
method
use
compar
differ
mous
mortal
rate
group
statist
analys
perform
use
graphpad
prism
graphpad
softwar
san
diego
ca
level
serum
control
mice
less
pgml
tabl
unexpectedli
mab
administr
strongli
augment
concentr
noninfect
anim
lesser
extent
mice
tabl
explor
possibl
increas
plasmat
concentr
produc
mab
high
level
circul
mabcytokin
complex
mean
bind
receptor
impair
thu
cytokin
function
alanin
aminotransferas
alt
occur
larg
concentr
heart
liver
moder
amount
skelet
muscl
kidney
pancrea
wherea
aspart
aminotransferas
ast
found
signific
quantiti
liver
kidney
skelet
muscl
decreas
order
describ
found
anim
exhibit
elev
serum
level
ast
day
treatment
figur
upon
treatment
mab
mice
show
signific
decreas
ast
level
figur
wherea
anim
inocul
mab
show
similar
level
enzym
control
anim
without
treatment
figur
addit
isotyp
control
mab
produc
effect
data
shown
later
time
transaminas
level
deepli
decreas
anim
effect
mab
anti
could
observ
data
shown
test
alt
well
alkalin
phosphatas
show
similar
result
data
shown
describ
previous
found
mice
show
higher
serum
ig
level
control
figur
hypergammaglobulinemia
still
amplifi
infect
anim
treat
mab
mainli
day
infect
figur
contrast
mice
inocul
mab
anti
show
signific
chang
ig
concentr
control
figur
infect
induc
product
day
treatment
neutral
significantli
exacerb
viru
effect
tabl
detect
anymor
day
treatment
andor
infect
data
shown
mab
alon
produc
effect
well
mab
use
control
tabl
plasmat
remain
undetect
level
pgml
whatev
treatment
andor
infect
alongsid
variou
time
studi
data
shown
observ
balbc
mice
induc
high
concentr
uric
acid
plasma
mice
use
work
show
lower
signific
plasmat
uric
acid
increas
mainli
day
infect
tabl
administr
mab
stimul
uric
acid
liber
control
anim
mab
induc
slight
increas
uric
acid
concentr
anim
tabl
howev
day
posttreat
mab
alon
significantli
increas
uric
acid
plasmat
level
control
mgml
respect
p
wherea
rest
paramet
like
describ
data
shown
result
obtain
day
infect
show
amount
serum
mice
similar
found
infect
treat
mab
sole
administr
mab
induc
releas
protein
data
shown
found
mab
augment
significantli
level
ast
induc
infect
figur
shown
figur
mab
treatment
strongli
increas
serum
ast
infect
anim
figur
effect
revert
simultan
inocul
mab
figur
slight
effect
mab
detect
noninfect
mice
use
control
figur
surprisingli
sole
treatment
mab
alon
presenc
mab
significantli
enhanc
level
ig
noninfect
anim
figur
autoab
liver
fah
induc
describ
character
previous
work
show
treatment
infect
anim
mab
alon
inocul
simultan
mab
strongli
decreas
autoab
antifah
mainli
day
infect
figur
furthermor
effect
mab
pronounc
autoab
detect
even
day
infect
figur
moreov
mab
effect
treatment
infect
anim
show
total
absenc
antifah
ab
day
infect
figur
b
day
treatment
andor
viral
infect
mice
show
surviv
anim
anim
infect
treat
mab
surviv
mice
differ
signific
accord
kaplanmei
test
data
shown
mous
die
control
group
mice
group
treat
mab
anim
similar
result
obtain
mab
treatment
liver
control
treat
andor
infect
mice
submit
siriu
red
stain
examin
possibl
presenc
histolog
fibrosi
detect
collagen
accumul
mice
treat
mab
case
observ
moder
sever
degre
fibrosi
occasion
portal
portal
bridg
data
shown
suggest
ishak
score
conclus
differ
liver
patholog
found
mice
treat
recent
progress
studi
cell
reveal
import
role
develop
allerg
autoimmun
diseas
well
protect
mechan
bacteri
fungal
infect
function
previous
believ
mediat
cell
herein
studi
effect
block
mice
togeth
simultan
treatment
mab
result
show
undetect
control
anim
wherea
mab
administr
increas
concentr
describ
result
mice
inocul
biotinyl
mab
complex
measur
elisa
high
level
bound
mab
found
conclud
mab
increas
vivo
halflif
cytokin
similar
observ
describ
previous
mab
previous
shown
mab
neutral
biolog
activ
high
level
circul
mabcytokin
mean
sequest
bind
receptor
ultim
mab
effect
decreas
biolog
activ
consequ
differ
level
bound
mab
found
control
anim
could
reflect
differenti
metabol
cytokin
situat
experiment
condit
neutral
mab
led
sharp
decreas
transaminas
releas
infect
effect
similar
report
kobayashi
et
al
model
halothaneinduc
liver
injuri
author
inform
intraperiton
administr
specif
mab
antimous
inocul
h
halothan
administr
reduc
plasmat
ast
alt
level
well
known
mice
develop
hypergammaglobulinemia
surprisingli
found
neutral
increas
ig
level
elicit
viru
infect
knowledg
report
demonstr
direct
relationship
ab
product
bcell
state
shibui
et
al
role
ig
product
b
cell
unclear
author
suggest
may
indirectli
involv
ab
product
releas
b
cell
activ
immun
cell
level
mous
serum
augment
describ
previous
yang
et
al
fulmin
liver
hepat
result
show
mab
administr
increas
significantli
plasmat
level
suggest
certain
control
releas
besid
wherea
mab
decreas
transaminas
liber
mab
greatli
augment
concentr
howev
simultan
administr
mab
reduc
transaminas
control
level
mab
augment
plasmat
ig
concentr
wherea
administr
mab
alon
inocul
mab
increas
valu
accord
know
immunolog
effect
one
expect
effici
protect
intracellular
pathogen
virus
known
activ
extracellular
pathogen
presum
play
neglig
protect
role
neutral
therefor
increas
liver
damag
henc
transaminas
level
hypergammaglobulinemia
wellknown
consequ
liver
inflamm
contrari
involv
liver
damag
neutral
decreas
hypergammaglobulinemia
well
transaminas
level
howev
decreas
instead
increas
hypergammaglobulinemia
observ
possibl
explan
could
follow
induc
hypergammaglobulinemia
indic
implic
cell
owe
mutual
inhibit
neutral
necessarili
increas
immun
effect
explain
increas
hypergammaglobulinemia
result
suggest
reciproc
regul
cell
regul
releas
liver
transaminas
ig
product
interplay
cell
lineag
describ
elsewher
hou
et
al
report
mani
viral
infect
includ
theiler
murin
encephalomyel
viru
result
vigor
product
author
suggest
togeth
synergist
enhanc
express
surviv
molecul
hinder
critic
host
defens
mechan
remov
virusinfect
cell
convers
result
present
herein
show
infect
enhanc
serum
use
mab
compar
effect
blockag
result
show
contrast
found
mab
mab
augment
transaminas
releas
accord
describ
mab
increas
transaminas
level
high
valu
wherea
simultan
treatment
mab
strongli
decreas
transaminas
concentr
surprisingli
mab
alon
inocul
simultan
mab
increas
ig
concentr
noninfect
anim
suggest
direct
effect
b
cell
furthermor
mab
chang
ig
concentr
anim
mab
show
small
effect
simultan
treatment
mab
alter
result
thu
result
suggest
interplay
cell
produc
shown
demonstr
earlier
presenc
autoab
liver
kidney
fah
sera
variou
mous
strain
due
adjuv
properti
least
uric
acid
remark
neutral
reduc
uric
acid
liber
abolish
autoab
fah
day
treatment
time
mab
augment
ig
concentr
enhanc
hypergammaglobulinemia
could
mask
exist
autoab
fah
howev
administr
mab
also
abolish
autoab
fah
wherea
effect
ig
plasmat
level
furthermor
sera
mice
treat
show
autoab
fah
neither
day
infect
treatment
thu
result
suggest
although
uric
acid
liber
necessari
induct
autoab
fah
action
alarmin
could
express
thank
presenc
andor
knowledg
first
time
regul
alarmin
cytokin
demonstr
broadli
accept
th
cell
coordin
immun
respons
produc
cytokin
mani
differ
thcell
subset
identifi
welldefin
effector
th
subset
includ
cell
make
cell
produc
cell
gener
cytokin
play
critic
role
regul
differenti
naiv
th
cell
differ
subset
effector
function
besid
report
cell
rel
unstabl
exhibit
function
plastic
particularli
site
inflamm
thu
cell
transit
stage
produc
lose
express
resembl
cell
although
liver
undergo
high
exposur
circul
antigen
gut
microbiota
maintain
special
local
immun
tolerogen
microenviron
toler
relev
chronic
persist
hepatotrop
virus
allograft
accept
liver
transplant
conserv
mechan
alarmin
tolllik
receptor
signal
inflammasom
activ
initi
inflammatori
respons
liver
final
result
intrahepat
immun
respons
fibrosi
resolut
depend
macrophag
dendrit
cell
function
also
balanc
proinflammatori
antiinflammatori
tcell
popul
experiment
condit
blockad
mab
suggest
cytokin
involv
variou
effect
although
exact
coincid
activ
describ
model
liver
patholog
prove
mechan
cite
act
concert
present
work
result
agre
statement
hammerich
et
al
exact
pathogen
contribut
cell
liver
inflamm
might
well
vari
upon
underli
diseas
exampl
infecti
autoimmun
disord
explor
effect
neutral
cytokin
variou
biolog
paramet
affect
mice
infect
main
find
studi
neutral
result
notabl
decreas
level
mous
transaminas
antifah
autoab
induc
viru
wherea
increas
ig
serum
secret
detect
express
antifah
autoab
associ
releas
uric
acid
remark
neutral
reduc
uric
acid
liber
abolish
autoab
fah
administr
mab
exhibit
effect
wherea
mice
infect
treat
show
autoab
fah
result
strongli
suggest
interplay
cell
act
mice
